Does it have as many benefits as we expect
The versatility of GLP-1 applications is also showcased in the context of IIH
However, because the studies differed considerably in how they measured these behaviors and the types of participants they enrolled, the authors caution that the pooled estimate should be interpreted carefully
Compile Your Health History Some people may not be a good fit for certain GLP-1sfor example, those with a personal or family history of Medullary Thyroid Cancer (MTC) or those who take other blood-sugar regulating medicationscombining the two can result in low blood sugar levels
Disclosures: Seema Alam: Nothing to Disclose, Bikrant Biharilal Raghuvanshi: Nothing to Disclose, Tamoghna Biswas: Nothing to Disclose, Vikrant Sood: Nothing to Disclose, Rajeev Khanna: Nothing to Disclose, Snigdha Verma: Nothing to Disclose 2113 IMPROVED OUTCOMES OF ACUTE LIVER FAILURE WITH EXTRACORPOREAL LIVER SUPPORT- A MORE THAN A DECADE OF EXPERIENCE FROM A TERTIARY CENTRE Rakhi Maiwall 1 Meenu Bajpai 2 Harsh Vardhan Tevethia 2 Samba Siva Rao Pasupuleti 3 Fagun Sharma 2 Bindiya Arora 2 Sumegh Talwalkar 2 Mohit kumar Prajapati 2 Prashant Agarwal 2 Rajendra Prasad Mathur 2 Chandani Bhagat 2 Sherin Thomas 2 Shiv Kumar Sarin 2 , 1 Institute of Liver and Biliary Sciences, 2 Institute of Liver & Biliary Sciences, 3 Mizoram University, Pachhunga University College Campus Background: There is a reduction in the deaths of acute liver failure (ALF) patients, with use of extracorporeal liver support systems (ECLS), therapeutic plasma-exchange (TPE) and continuous renal replacement therapy (CRRT)
